Infinity Pharmaceuticals, Inc.

DB:I3F Stock Report

Market Cap: €256.3k

Infinity Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of I3F?
Owner TypeNumber of SharesOwnership Percentage
Private Companies00%
Institutions291,2420.321%
Individual Insiders2,476,4122.73%
General Public87,993,42797%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 12 shareholders own 2.93% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
1.31%
Adelene Perkins
1,191,738€3.4k42.9%no data
1.07%
Lawrence Bloch
966,932€2.7k0%no data
0.24%
Anthony Evnin
215,403€608.30%no data
0.2%
XTX Holdings Limited, Asset Management Arm
181,068€511.40%no data
0.041%
Stephane Peluso
37,052€104.60%no data
0.034%
Brian Schwartz
30,919€87.30%no data
0.017%
Norman Selby
15,000€42.40%no data
0.012%
Samuel Agresta
10,593€29.90%no data
0.0097%
David Beier
8,775€24.80%no data
0.0039%
Highlander Capital Management LLC
3,500€9.90%no data
0.0011%
SagePoint Financial Advisors, Inc., Securities Investments
1,000€2.80%no data
0.00011%
Steward Partners Investment Advisory, LLC
100€0.30%no data